DNAJC5 and malaria: Although the definitive immune correlates of the RTS,S/AS01 protection has not been established yet, the vaccine-induced anti-CSP IgG antibodies against the NANP region of CSP have been associated with the vaccine efficacy from clinical trials with malaria episodes endpoint [7, 24, 25].